Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.43 |
| ▸ | ASPH | Q12797 | 1/20 | 0.42 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.42 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.36 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.35 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | RBP4 | P02753 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3107649 | 0.91 | PTGDR2 (0.50) | SLC6A2SLC6A4SLC6A3ASPHKDM8 | |
| SCHEMBL7968570 | 0.86 | AKR1B1 (0.53) | SLC6A2SLC6A4SLC6A3ASPHKDM8 | |
| SCHEMBL11359967 | 0.85 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3ASPHKDM8 | |
| SCHEMBL17080017 | 0.80 | KDM4E (0.46) | SLC6A2SLC6A4SLC6A3ASPHKDM8 | |
| SCHEMBL3633503 | 0.79 | PTGDR2 (0.54) | SLC6A2SLC6A4SLC6A3ASPHKDM8 | |
| SCHEMBL3979460 | 0.78 | PTGDR2 (0.45) | SLC6A2SLC6A4SLC6A3ASPHKDM8 | |
| SCHEMBL2550680 | 0.78 | PTGDR2 (0.56) | PTGDR2NAAAAKR1B1 | |
| SCHEMBL5049599 | 0.78 | PTGDR2 (0.42) | SLC6A2SLC6A4SLC6A3ASPHKDM8 | |
| SCHEMBL21767564 | 0.78 | PKM (0.48) | SLC6A2SLC6A4SLC6A3HSD17B10ALDH1A1 | |
| SCHEMBL7135459 | 0.77 | HCRTR2 (0.45) | SLC6A2SLC6A4SLC6A3ASPHKDM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2242736-B1 | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL INTERMEDIATES | EGIS GYOGYSZERGYAR NYILVANOSAN MUEKOEDOE RESZVENYTARSASAG (HU) | 2011-09-14 | — | — | EP | disclosed |
| US-20110040093-A1 | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL INTERMEDIATE | EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG (HU) | 2011-02-17 | — | — | US | disclosed |
| EP-2242736-A1 | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL I NTERM EDIATES | Egis Gyógyszergyár Nyilvánosan Müködö Részvénytársaság (HU) | 2010-10-27 | — | — | EP | disclosed |
| WO-2009068924-A1 | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL I NTERM EDIATES | EGIS GYÓGYSZERGYÁR NYILVÁNOSAN MÜKÖDÖ (HU) | 2009-06-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110040093-A1 | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL INTERMEDIATE | CYP2F1, CYP4F3, CYP4F11 | SLC6A2 2537/4885SLC6A4 2058/4885SLC6A3 1005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.